Sanofi’s Xenpozyme approved by European Commission
Xenpozyme is a treatment for ASMD and the condition’s only current enzyme replacement therapy
Read More
Tag: Xenpozyme
CHMP recommends Sanofi’s Xenpozyme for rare disease ASMD
Positive opinion is based on data from clinical trials which showed improvement in lung function
Read More
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
- Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
- Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
- BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development
- Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026
